Cargando…

Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases

BACKGROUND: Amyloidoses are a heterogeneous group of progressive diseases caused by tissue deposition of misfolded proteins. According to the International Classification of Diseases, hereditary amyloidosis is divided into neuropathic and non-neuropathic forms. In Sweden, neuropathic heredofamilial...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemminki, Kari, Li, Xinjun, Försti, Asta, Sundquist, Jan, Sundquist, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766062/
https://www.ncbi.nlm.nih.gov/pubmed/24138840
http://dx.doi.org/10.1186/1471-2350-14-88
_version_ 1782283455095111680
author Hemminki, Kari
Li, Xinjun
Försti, Asta
Sundquist, Jan
Sundquist, Kristina
author_facet Hemminki, Kari
Li, Xinjun
Försti, Asta
Sundquist, Jan
Sundquist, Kristina
author_sort Hemminki, Kari
collection PubMed
description BACKGROUND: Amyloidoses are a heterogeneous group of progressive diseases caused by tissue deposition of misfolded proteins. According to the International Classification of Diseases, hereditary amyloidosis is divided into neuropathic and non-neuropathic forms. In Sweden, neuropathic heredofamilial amyloidosis has been identified as familial amyloidotic polyneuropathy (FAP), a fatal disease that is treated by liver transplantation. The non-neuropathic form includes familial autoinflammatory diseases. As no incidence data on these hereditary diseases are available and as even diagnostic data on non-neuropathic forms are lacking we determined the incidence of these diseases and characterized non-neuropathic conditions. METHODS: Patients were identified using data from the Swedish Hospital Discharge Register and from the Outpatient Register for 2001 through 2008. All patients discharged with hereditary amyloidosis diagnoses were included and standardized incidence rates were calculated. RESULTS: Non-neuropathic disease was diagnosed in 210 patients, with an incidence of 2.83 per million. FAP was diagnosed in 221 patients, with an incidence of 2.02 per million. Two northern provinces that are home to 5% of the Swedish population accounted for 77% of FAP cases; the incidence in one of them, West Bothnia, was 100 times that in the rest of Sweden. Approximately 98% of non-neuropathic disease patients were immigrants, most of whom were from the Eastern Mediterranean area. Young Syrian descendants had the highest incidence rate, which was over 500-fold higher than that in individuals with Swedish parents. Even the early onset of these conditions identified them as familial autoinflammatory diseases. CONCLUSIONS: FAP cases were highly concentrated in the two northernmost provinces. Non-neuropathic familial autoinflammatory diseases were of early-onset and immigrant origin most likely related to periodic fever syndromes. Paradoxically, FAP has remained endemic, in spite of population movements within the country, while familial autoinflammatory diseases, with an incidence exceeding that of FAP, were brought into the country as a result of immigration mainly from the Eastern Mediterranean area.
format Online
Article
Text
id pubmed-3766062
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37660622013-09-08 Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases Hemminki, Kari Li, Xinjun Försti, Asta Sundquist, Jan Sundquist, Kristina BMC Med Genet Research Article BACKGROUND: Amyloidoses are a heterogeneous group of progressive diseases caused by tissue deposition of misfolded proteins. According to the International Classification of Diseases, hereditary amyloidosis is divided into neuropathic and non-neuropathic forms. In Sweden, neuropathic heredofamilial amyloidosis has been identified as familial amyloidotic polyneuropathy (FAP), a fatal disease that is treated by liver transplantation. The non-neuropathic form includes familial autoinflammatory diseases. As no incidence data on these hereditary diseases are available and as even diagnostic data on non-neuropathic forms are lacking we determined the incidence of these diseases and characterized non-neuropathic conditions. METHODS: Patients were identified using data from the Swedish Hospital Discharge Register and from the Outpatient Register for 2001 through 2008. All patients discharged with hereditary amyloidosis diagnoses were included and standardized incidence rates were calculated. RESULTS: Non-neuropathic disease was diagnosed in 210 patients, with an incidence of 2.83 per million. FAP was diagnosed in 221 patients, with an incidence of 2.02 per million. Two northern provinces that are home to 5% of the Swedish population accounted for 77% of FAP cases; the incidence in one of them, West Bothnia, was 100 times that in the rest of Sweden. Approximately 98% of non-neuropathic disease patients were immigrants, most of whom were from the Eastern Mediterranean area. Young Syrian descendants had the highest incidence rate, which was over 500-fold higher than that in individuals with Swedish parents. Even the early onset of these conditions identified them as familial autoinflammatory diseases. CONCLUSIONS: FAP cases were highly concentrated in the two northernmost provinces. Non-neuropathic familial autoinflammatory diseases were of early-onset and immigrant origin most likely related to periodic fever syndromes. Paradoxically, FAP has remained endemic, in spite of population movements within the country, while familial autoinflammatory diseases, with an incidence exceeding that of FAP, were brought into the country as a result of immigration mainly from the Eastern Mediterranean area. BioMed Central 2013-09-03 /pmc/articles/PMC3766062/ /pubmed/24138840 http://dx.doi.org/10.1186/1471-2350-14-88 Text en Copyright © 2013 Hemminki et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hemminki, Kari
Li, Xinjun
Försti, Asta
Sundquist, Jan
Sundquist, Kristina
Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title_full Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title_fullStr Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title_full_unstemmed Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title_short Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases
title_sort incidence of hereditary amyloidosis and autoinflammatory diseases in sweden: endemic and imported diseases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766062/
https://www.ncbi.nlm.nih.gov/pubmed/24138840
http://dx.doi.org/10.1186/1471-2350-14-88
work_keys_str_mv AT hemminkikari incidenceofhereditaryamyloidosisandautoinflammatorydiseasesinswedenendemicandimporteddiseases
AT lixinjun incidenceofhereditaryamyloidosisandautoinflammatorydiseasesinswedenendemicandimporteddiseases
AT forstiasta incidenceofhereditaryamyloidosisandautoinflammatorydiseasesinswedenendemicandimporteddiseases
AT sundquistjan incidenceofhereditaryamyloidosisandautoinflammatorydiseasesinswedenendemicandimporteddiseases
AT sundquistkristina incidenceofhereditaryamyloidosisandautoinflammatorydiseasesinswedenendemicandimporteddiseases